Concepedia

Belinda R. Avalos

BR

50

Publications

3.3K

Citations

27

H-Index

1991

Active since

Affiliations

The Ohio State University(Current)

Levine Cancer Institute

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Cleveland Clinic

Carolinas Healthcare System

Belinda R. Avalos is an author at The Ohio State University specializing in medicine, immunology, and hematology.

ORCID

Top concepts

Publications per year

1991–2024

50

Publications

50

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

Richard A. Nash, Joseph H. Antin, Chatchada Karanes et al. · PubMed · 2000 · 591 citations

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka et al. · PubMed · 1998 · 568 citations

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Edward A. Copelan, Betty K. Hamilton, Belinda R. Avalos et al. · Blood · 2013 · 182 citations · Full text

Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation.

Lynn O’Donnell, Lawrence J. Druhan, Belinda R. Avalos · PubMed · 2002 · 170 citations

, , +22

Molecular characterization and expression analysis of leucine-rich α2-glycoprotein, a novel marker of granulocytic differentiation

Lynn O’Donnell, Lawrence J. Druhan, Belinda R. Avalos · Journal of Leukocyte Biology · 2002 · 164 citations · Full text

, , +24

Rows per page

1–5 of 50